The FDA recently accepted the New Drug Application (“NDA”) submission for CUTX-101 (copper histidinate for Menkes disease) for priority review with a PDUFA goal date of September 30, 2025. In December ...

Liver disease is a broad term that can describe any issue that damages the liver and affects its function. Possible causes include infections, genetic conditions, autoimmune disorders, and cancer.